These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10458258)

  • 1. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers: a review of the problem.
    Liang R; Lau GK; Kwong YL
    J Clin Oncol; 1999 Jan; 17(1):394-8. PubMed ID: 10458258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation.
    Lau GK; Liang R; Wu PC; Lee CK; Lim WL; Au WY
    J Hepatol; 1998 Mar; 28(3):359-68. PubMed ID: 9551671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature.
    Kempinska A; Kwak EJ; Angel JB
    Clin Infect Dis; 2005 Nov; 41(9):1277-82. PubMed ID: 16206102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.
    Lau GK; Lok AS; Liang RH; Lai CL; Chiu EK; Lau YL; Lam SK
    Hepatology; 1997 Jun; 25(6):1497-501. PubMed ID: 9185774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological changes during clearance of chronic hepatitis B virus infection by adoptive immunity transfer.
    Lau GK; Yuen ST; Au WY; Wu PC; Liang R
    J Gastroenterol Hepatol; 1999 Mar; 14(3):262-8. PubMed ID: 10197497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B associated liver failure following bone marrow transplantation.
    Caselitz M; Link H; Hein R; Maschek H; Böker K; Poliwoda H; Manns MP
    J Hepatol; 1997 Sep; 27(3):572-7. PubMed ID: 9314136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of viral hepatitis in hematologic malignancies.
    Firpi RJ; Nelson DR
    Blood Rev; 2008 May; 22(3):117-26. PubMed ID: 18343002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.
    Locasciulli A; Bacigalupo A; Van Lint MT; Chemello L; Pontisso P; Occhini D; Uderzo C; Shulman HM; Portmann B; Marmont AM
    Bone Marrow Transplant; 1990 Jul; 6(1):25-9. PubMed ID: 2390630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.
    Yeo W; Ho WM; Hui P; Chan PK; Lam KC; Lee JJ; Johnson PJ
    Breast Cancer Res Treat; 2004 Dec; 88(3):209-15. PubMed ID: 15609123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
    J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral efficacy analysis of telbivudine concurrent with the first cycle of chemotherapy in HBsAg-positive lymphoma patients.
    Li W; Huang L; Guo H; Wei X; Liang Z
    J Clin Virol; 2014 Oct; 61(2):199-203. PubMed ID: 25128391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.
    Moses SE; Lim ZY; Sudhanva M; Devereux S; Ho AY; Pagliuca A; Zuckerman M; Mufti GJ
    J Med Virol; 2006 Dec; 78(12):1560-3. PubMed ID: 17063522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors.
    Ilan Y; Nagler A; Shouval D; Ackerstein A; Or R; Kapelushnik J; Adler R; Slavin S
    Clin Exp Immunol; 1994 Aug; 97(2):299-302. PubMed ID: 8050180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor.
    Ilan Y; Nagler A; Adler R; Tur-Kaspa R; Slavin S; Shouval D
    Gastroenterology; 1993 Jun; 104(6):1818-21. PubMed ID: 8500741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reverse seroconversion of hepatitis B virus infectious status after allogeneic bone marrow transplantation from a carrier donor.
    Fan FS; Tzeng CH; Yeh HM; Chen PM
    Bone Marrow Transplant; 1992 Aug; 10(2):189-91. PubMed ID: 1525609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
    Huang H; Cai Q; Lin T; Lin X; Liu Y; Gao Y; Peng R
    Expert Opin Pharmacother; 2009 Oct; 10(15):2399-406. PubMed ID: 19761353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients.
    Ilan Y; Nagler A; Zeira E; Adler R; Slavin S; Shouval D
    Bone Marrow Transplant; 2000 Sep; 26(6):633-8. PubMed ID: 11035369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ; Hsu C; Song YQ; Tay K; Hong XN; Cao J; Kim JS; Eom HS; Lee JH; Zhu J; Chang KM; Reksodiputro AH; Tan D; Goh YT; Lee J; Intragumtornchai T; Chng WJ; Cheng AL; Lim ST; Suh C; Kwong YL; Kim WS
    Eur J Cancer; 2013 Nov; 49(16):3486-96. PubMed ID: 23910494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.